Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0422
-0.0042 (-9.16%)
At close: Mar 2, 2026
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $18.68 million as of March 2, 2026. Its market cap has increased by 52.88% in one year.
Market Cap
18.68M
Enterprise Value
31.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 18.68M, an increase of 104.30%. That is a compound annual growth rate of 10.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 20.56M | -44.62% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 37.60M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Zenith Capital | 23.96M |
| EOM Pharmaceuticals Holdings | 22.73M |
| Finch Therapeutics Group | 21.28M |
| Provectus Biopharmaceuticals | 20.34M |
| Zeo ScientifiX | 18.93M |
| Anebulo Pharmaceuticals | 17.71M |